Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease

Obesity Surgery

Volumn 20, Issue 5, 2010, Pages 640-650

  Stepanova, Maria ^a,b   Hossain, Noreen ^b   Afendy, Arian ^a,b   Perry, Kellie ^c   Goodman, Zachary D ^d   Baranova, Ancha ^a,b,c   Younossi, Zobair ^a,b,c  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

^d ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

NAFLD; NASH

Indexed keywords

COMPLEMENTARY DNA; CYTOCHROME P450 3A; ERYTHROCYTE MEMBRANE PROTEIN BAND 4.1 LIKE 1; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 4; FUMARYLACETOACETASE; GENE PRODUCT; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M2; GLUTATHIONE TRANSFERASE M4; GLUTATHIONE TRANSFERASE M5; LONG CHAIN FATTY ACID COENZYME A LIGASE; LONG CHAIN FATTY ACID COENZYME A LIGASE 4; MEMBRANE PROTEIN; RNA; SOMATOMEDIN B; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; BARIATRIC SURGERY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ADULT; AFRICAN AMERICANS; BIOPSY; BLOOD CHEMICAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACIDS; FATTY LIVER; FEMALE; GENE EXPRESSION; HUMANS; MALE; OBESITY, MORBID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS;

EID: 77953287827     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-010-0078-2     Document Type: Article

References (36)

1. Rafiq N, Younossi ZM. Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Clin Liver Dis. 2009; 13(2): 249-266
2. Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis. 2007; 11(1): 1-16. (Pubitemid 46829973)
3. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116(6): 1413-1419 (Pubitemid 29258890)
4. Bondini S, Kleiner DE, Goodman ZD, et al. Pathologic assessment of non-alcoholic fatty liver disease. Clin Liver Dis. 2007; 11(1): 17-23. (Pubitemid 46829967)
5. Rafiq N, Bai C, Fang Y, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol. 2009; 7 (2): 234-238
6. Ong JP, Younossi ZM. Is hepatocellular carcinoma part of the natural history of non-alcoholic steatohepatitis? Gastroenterology 2002; 123(No.1): 375-378
7. Caldwell SH, Oelsner DH, Iezzoni JC, et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999; 29(3): 664-669 (Pubitemid 29109578)
8. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third. National Health and Nutrition Examination Survey. JAMA. 2002; 287 (3): 356-359
9. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003; 37(4): 917-923 (Pubitemid 36397405)
10. Fan-ell GC, Chitturi S, Lau GK, Asia-Pacific Working Party on NAFLD, et al. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol. 2007; 22(6): 775-777
11. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008; 28(4): 339-350
12. Uchil D, Pipalia D, Chawla M, et al. Non-alcoholic fatty liver disease (NAFLD)-the hepatic component of metabolic syndrome. J Assoc Physicians India. 2009; 57: 201-204
13. Younossi ZM, Diehl AM, Ong JP. Non-alcoholic fatty liver disease: an agenda for clinical research. Hepatology. 2002; 35 (No.4): 746-752 (Pubitemid 34258367)
14. Younossi ZM. Current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2008; 28(1): 2-12. (Pubitemid 351782816)
15. Ong JP, Elariny H, Collantes R, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in obese patients. Obes Surg. 2005; 15(3): 310-315 (Pubitemid 40463594)
16. Manco M, Bottazzo G, DeVito R, et al. Nonalcoholic fatty liver disease in children. J Am Coll Nutr. 2008; 27(6): 667-676
17. Clark. JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006; 40(S1): 5-10.
18. Kallwitz ER, Guzman G, TenCate V, et al. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. Am J Gastroenterol. 2009; 104(1): 64-69
19. Mohanty SR, Troy TN, Huo D, et al. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. J Hepatol. 2009; 50(4): 797-804.
20. Rivera CA. Risk factors and mechanisms of non-alcoholic steatohepatitis. Pathophysiology. 2008; 15(2): 109-114
21. Caldwell SH, Harris DM, Patrie JT, et al. Is NASH underdiagnosed among African Americans? Am J Gastroenterol. 2002; 97(6): 1496-1500
22. Anonymous. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19): 2486-2497
23. Gramlich T, Kleiner D, McCullough A, et al. Pathologic features associated with fibrosis in non-alcoholic fatty liver disease. Human Pathol. 2004; 35(2): 196-199 (Pubitemid 38240902)
24. Younossi ZM, Gorreta F, Ong JP, et al. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int. 2005; 25(4): 760-771 (Pubitemid 41038658)
25. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001; 98(9): 5116-5121 (Pubitemid 32397092)
26. Facer CA. Erythrocytes carrying mutations in spectrin and protein 4.1 show differing sensitivities to invasion by Plasmodium falciparum. Parasitol Res. 1995; 81(1): 52-57
27. El-Shewy HM, Luttrell LM. Insulin-like growth factor-2/mannose-6 phosphate receptors. Vitam Horm. 2009; 80: 667-697
28. Chiappini F, Barrier A, Saffroy R, et al. Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray Lab Invest. 2006; 86(2): 154-165
29. Westerbacka J, Kolak M, Kiviluoto T, et al. Genes involved in fatty acid, partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes. 2007; 56 (11): 2759-2765 (Pubitemid 350044919)
30. Vogel A, van Den Berg IE, Al-Dhalimy M, et al. Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death. Hepatology. 2004; 39(2): 433-443
31. Azuma Y, Ito M, Taniguchi A, et al. Expression of cell surface Lewis X and Y antigens and FUT4 mRNA is increased in Jurkat cells undergoing apoptosis. Biochim Biophys Acta. 2004; 1672 (3): 157-163
32. J'akobsson M, Scholz SW, Scheet P, et al. Genotype, haplotype and copy-number variation in worldwide human populations. Nature. 2008; 451(7181): 998-1003.
33. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003; 163: 427-436
34. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA. 2002; 287(3): 356-359
35. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005; 102(43): 15545-15550
36. Younossi Z, Baranova A, Ziegler K, et al. A genomic and proteomic of study of the spectrum of non-alcoholic fatty liver disease. Hepatology. 2005; 41(3): 665-674 (Pubitemid 41233660)